EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A new principle to attenuate ischemia-reperfusion injury in kidney transplantation

Ali-Reza Biglarnia, Yuji Teramura, Sana Asif, Claudia Dührkop, Vivek Anand Manivel, Elin Manell, Patricia Hedenqvist, Anneli Rydén, Felix Sellberg, Karin Fromell, Sabine Hammer, Markus Huber-Lang und 3 weitere

American Journal of Transplantation · 2026-02 · 26 (2) · 263-275

DOI: 10.1016/j.ajt.2025.08.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Transplantation, 2026-02. Verfasst von Ali-Reza Biglarnia und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Department of Clinical Sciences Malmö, University Hospital, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Reperfusion Injury, Kidney Transplantation, Polyethylene Glycols, Graft Rejection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STINT, Ministry of Education, Culture, Sports, Science and Technology, European Commission Seventh Framework Programme for Research and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemia-reperfusion injury in transplantation remains a significant clinical challenge with regard to both short-term and long-term complications. In this study, we developed a new amphiphilic construct, polyethylene glycol (PEG)-conjugated lipids (PEG-LIPIDs), to be administered ex vivo intra-arterially to procured porcine kidney allografts before reperfusion. The aim was to create a protective cell membrane barrier, preventing the recognition of ligands exposed on renal cells by plasma proteins and cells of the intravascular innate immune system. In vitro cell studies confirmed the safety of PEG-LIPID with no observed toxicity and demonstrated its efficacy in masking ligands on various cell types. The PEG-LIPID was evaluated in 3 porcine allogeneic transplant models: 1 acute dual en bloc nonsurvival transplant model (duration 6 hours) and 2 survival models with low and high ischemic stress, respectively (duration 96 hours). No immunosuppression was employed. Across all 3 porcine transplant models, PEG-LIPID consistently mitigated ischemia-reperfusion-induced thromboinflammation (complement, coagulation, and kallikrein/kinin activation) and long-term inflammation with a marked reduction in cytokine responses, including lower levels of interleukin 6. The PEG-LIPID-treated kidneys exhibited significantly improved allograft function, reflected in robustly lower creatinine levels. This translational study confirmed that the PIG-LIPID is a strong candidate drug to mitigate ischemia-reperfusion injury in clinical kidney transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryKidney TransplantationPolyethylene GlycolsGraft RejectionLipidsAnimalsSwineGraft SurvivalKidney Function Tests

Stichwörter der Autor:innen

intravascular innate immunityischemia-reperfusion injurykidney transplantationpretreatment modality

Substanzen

Polyethylene GlycolsLipids

Autor:innen und Institutionen

  • Department of Surgery, Department of Clinical Sciences Malmö, University Hospital, Lund University, Malmö, Sweden.
  • Department of Immunology, Genetics, and Pathology (IGP), Rudbeck Laboratory C5:3, Uppsala University, Uppsala, Sweden; Cellular and Molecular Biotechnology Research Institute (CMB), National Institute of Advanced Indust…
  • Department of Immunology, Genetics, and Pathology (IGP), Rudbeck Laboratory C5:3, Uppsala University, Uppsala, Sweden.
  • Department of Clinical Sciences, Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Immunology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Institute for Clinical and Experimental Trauma-Immunology, University Hospital of Ulm, Ulm, Germany.

Förderung

  • STINT
  • Ministry of Education, Culture, Sports, Science and Technology
  • European Commission Seventh Framework Programme for Research and Technological Development
  • Vetenskapsrådet
  • Japan Society for the Promotion of Science
  • Seventh Framework Programme
  • Linnéuniversitetet

Zitieren

APA

Biglarnia, A. R., Teramura, Y., Asif, S., Dührkop, C., Manivel, V. A., Manell, E., Hedenqvist, P., Rydén, A., Sellberg, F., Fromell, K., Hammer, S., Huber-Lang, M., Ekdahl, K. N., Jensen-Waern, M., & Nilsson, B. (2026). A new principle to attenuate ischemia-reperfusion injury in kidney transplantation. American Journal of Transplantation, 26(2), 263-275. https://doi.org/10.1016/j.ajt.2025.08.024

Vancouver

Biglarnia AR, Teramura Y, Asif S, Dührkop C, Manivel VA, Manell E, et al. A new principle to attenuate ischemia-reperfusion injury in kidney transplantation. American Journal of Transplantation. 2026;26(2):263-275. doi:10.1016/j.ajt.2025.08.024

BibTeX
@article{Biglarnia2026,
  author = {Biglarnia, Ali-Reza and Teramura, Yuji and Asif, Sana and Dührkop, Claudia and Manivel, Vivek Anand and Manell, Elin and Hedenqvist, Patricia and Rydén, Anneli and Sellberg, Felix and Fromell, Karin and Hammer, Sabine and Huber-Lang, Markus and Ekdahl, Kristina N and Jensen-Waern, Marianne and Nilsson, Bo},
  title = {A new principle to attenuate ischemia-reperfusion injury in kidney transplantation},
  journal = {American Journal of Transplantation},
  year = {2026},
  volume = {26},
  number = {2},
  pages = {263--275},
  doi = {10.1016/j.ajt.2025.08.024}
}
Kostenlos starten →